Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity.
Biomarker and diagnostic research for malignant epithelioid mesothelioma has been reported in the published literature.
4 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, procedural interventions, and other interventions. Pipeline includes 1 PHASE2, 3 PHASE1. Research is primarily sponsored by academic and government institutions.
121 publications have been identified in PubMed for malignant epithelioid mesothelioma. Kisho has analyzed 85 by research type. Research spans Case Report / Case Series (22%), Review / Meta-Analysis (18%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:51 PM UTC
22% |
Research summaries | 15 | 18% |
Clinical study results | 14 | 16% |
Laboratory research | 12 | 14% |
Testing and diagnosis research | 11 | 13% |
Disease patterns and progression | 11 | 13% |
Other research | 2 | 2% |
New treatment approaches | 1 | 1% |
Aoe K (2026). [PMID: 41410266](https://pubmed.ncbi.nlm.nih.gov/41410266/). *Pathology international*. [Diagnostic / Biomarker]
Zhan PL (2026). [PMID: 40588180](https://pubmed.ncbi.nlm.nih.gov/40588180/). *Ann Thorac Surg*. [Epidemiology / Natural History]
Sallé FG (2026). [PMID: 41962769](https://pubmed.ncbi.nlm.nih.gov/41962769/). *Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer*. [Review / Meta-Analysis]
Andresen JR (2026). [PMID: 41523226](https://pubmed.ncbi.nlm.nih.gov/41523226/). *Journal of surgical case reports*. [Case Report / Case Series]
Skelin M (2026). [PMID: 40264298](https://pubmed.ncbi.nlm.nih.gov/40264298/). *J Chemother*. [Review / Meta-Analysis]
Gan X (2026). [PMID: 41970397](https://pubmed.ncbi.nlm.nih.gov/41970397/). *Front Med (Lausanne)*. [Case Report / Case Series]
Isaacson AL (2026). [PMID: 41886900](https://pubmed.ncbi.nlm.nih.gov/41886900/). *Semin Diagn Pathol*. [Review / Meta-Analysis]
Al Achkar Z (2026). [PMID: 42026555](https://pubmed.ncbi.nlm.nih.gov/42026555/). *BMC Pulm Med*. [Review / Meta-Analysis]
Abdelaziz AO (2026). [PMID: 42186690](https://pubmed.ncbi.nlm.nih.gov/42186690/). *J Pathol Transl Med*. [Basic Science / Preclinical]
Thabit DM (2026). [PMID: 42135065](https://pubmed.ncbi.nlm.nih.gov/42135065/). *J Clin Pathol*. [Diagnostic / Biomarker]
AI-curated news mentioning malignant epithelioid mesothelioma
Updated Apr 23, 2026
A study analyzes seven cases of malignant epithelioid mesenchymal neoplasms with EWSR1/FUS::CREM fusions, revealing significant immunophenotypic heterogeneity and aggressive behavior. The findings highlight potential diagnostic challenges in identifying these neoplasms.